Previous Close | 251.88 |
Open | 251.53 |
Bid | 252.23 x 800 |
Ask | 252.96 x 1400 |
Day's Range | 245.67 - 256.56 |
52 Week Range | 56.54 - 282.64 |
Volume | 221,265 |
Avg. Volume | 404,448 |
Market Cap | 7.297B |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.89 |
Earnings Date | Feb 25, 2021 - Mar 01, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 244.13 |
Shares of iRhythm Technologies (NASDAQ: IRTC), which makes wearable biosensors for detecting cardiac arrhythmias, soared 248% in 2020, according to data from S&P Global Market Intelligence. It's down 6.5% through Jan. 7, whereas the broader market has returned 2% over this period.
SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Tuesday, January 12, 2021 at 2:50 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: www.irhythmtech.com.About iRhythm Technologies, Inc. iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.Investor Relations Contact Lynn Pieper Lewis or Leigh Salvo (415) 937-5404 investors@irhythmtech.com Media Contact Saige Smith (262) 289-7065 irhythm@highwirepr.com
Brown Capital Management Small Company Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 5.35% (instl. class) for the quarter, underperforming its benchmark, the Russell 2,000 Growth Index which returned 7.16% in the same quarter. You should check out Brown Capital Management’s […]